Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oestrogen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05877235
What this trial is testing

Serum Concentration of Endogenous Estrogens and Sirtuin-1 After Administration of Atorvastatin and Quercetin:

Who this might be right for
Coronary Artery DiseaseMenopause
InCor Heart Institute 60
Testing effectiveness (Phase 2)Study completedNCT05054374
What this trial is testing

Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer

Who this might be right for
Breast CancerBreast Cancer Stage IVHER2-negative Breast Cancer+4 more
Memorial Sloan Kettering Cancer Center 6
Early research (Phase 1)Study completedNCT03752398
What this trial is testing

XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Who this might be right for
Melanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more
Xencor, Inc. 198
Testing effectiveness (Phase 2)Study completedNCT00114517
What this trial is testing

ELITE: Early Versus Late Intervention Trial With Estradiol

Who this might be right for
Atherosclerosis
University of Southern California 643
Testing effectiveness (Phase 2)Study completedNCT01173497
What this trial is testing

A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis

Who this might be right for
Estrogen Receptor Negative (ER-Negative) Breast CancerProgesterone Receptor Negative (PR-Negative) Breast CancerHuman Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer+1 more
Sanofi 44
Testing effectiveness (Phase 2)Study completedNCT00856050
What this trial is testing

Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma

Who this might be right for
Leiomyosarcoma
Dana-Farber Cancer Institute 27
Early research (Phase 1)Active Not RecruitingNCT04288089
What this trial is testing

H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer

Who this might be right for
Receptors, EstrogenGenes, Erbb-2Breast Neoplasms
Eisai Inc. 31
Testing effectiveness (Phase 2)Ended earlyNCT00131924
What this trial is testing

High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy

Who this might be right for
Breast Cancer
Northwestern University 1
Testing effectiveness (Phase 2)Study completedNCT00305825
What this trial is testing

Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery

Who this might be right for
Breast Cancer
University of California, San Francisco 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT06008158
What this trial is testing

Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Estrogen Receptor-Positive Breast Carcinoma+1 more
City of Hope Medical Center 48
Testing effectiveness (Phase 2)Study completedNCT00602043
What this trial is testing

F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerProgesterone Receptor-negative Breast CancerProgesterone Receptor-positive Breast Cancer+2 more
National Cancer Institute (NCI) 20
Large-scale testing (Phase 3)Study completedNCT00556374
What this trial is testing

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
Amgen 3,420
Testing effectiveness (Phase 2)Study completedNCT00973674
What this trial is testing

Resuscitative Endocrinology:Single-dose Clinical Uses for Estrogen-Traumatic Brain Injury

Who this might be right for
Traumatic Brain Injury
University of Texas Southwestern Medical Center 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07260825
What this trial is testing

Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial

Who this might be right for
VulvodyniaDyspareuniaLichen Sclerosus of Vulva
TriHealth Inc. 44
Large-scale testing (Phase 3)Study completedNCT00863655
What this trial is testing

Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 724
Large-scale testing (Phase 3)Looking for participantsNCT02535221
What this trial is testing

Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer

Who this might be right for
Breast Cancer
Peking University 234
Testing effectiveness (Phase 2)Study completedNCT03689543
What this trial is testing

Estrogen Receptor Beta and Mood

Who this might be right for
Perimenopause-Related Depression
National Institute of Mental Health (NIMH) 74
Testing effectiveness (Phase 2)Study completedNCT02015559
What this trial is testing

Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerOral Complications+5 more
Jonsson Comprehensive Cancer Center 61
Testing effectiveness (Phase 2)Study completedNCT01880086
What this trial is testing

Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration

Who this might be right for
HypogonadismOpioid-Related DisordersMale Infertility
Weill Medical College of Cornell University 13
Not applicableStudy completedNCT01461070
What this trial is testing

Intestine Bacteria and Breast Cancer Risk

Who this might be right for
Breast Neoplasms
National Cancer Institute (NCI) 175
Next Page